Finanzwire Finanzwire
Basculer en Français
11224 Companies
248921 Keywords
176726 Articles
134739 Press releases
Headlines Articles Press releases HAL Allergy B.V. Remove
  1. Home
  2. Companies
  3. HAL Allergy B.V.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 09/02/2026 at 10:08, 1 month 23 days ago

    HAL Allergy and InfectoPharm Form Strategic Partnership for ENT Digital Health

    Digital Health HAL Allergy InfectoPharm Tinnitus App ENT Care
  • PRESS RELEASE

    published on 09/02/2026 at 10:03, 1 month 23 days ago

    Strengthening modern hybrid patient care: HAL Allergy and InfectoPharm enter into strategic partnership for digital health applications in ENT

    HAL Allergy and InfectoPharm enter strategic partnership for digital health applications in ENT, focusing on patient care and innovative treatment components
    Digital Health Partnership HAL Allergy InfectoPharm ENT
    Logo of HAL Allergy B.V.
  • BRIEF

    published on 06/15/2026 at 09:05, 4 months 10 days ago

    HAL Allergy Completes Phase III Study on Dust Mite Allergy

    Clinical Trials Phase III Study Dust Mite Allergy Allergen Immunotherapy HAL Allergy
  • PRESS RELEASE

    published on 06/15/2026 at 09:00, 4 months 10 days ago

    New research results in house dust mite allergy: HAL Allergy completes large Phase III study

    HAL Allergy completes large Phase III study on house dust mite allergy, showing significant improvements in allergy symptoms and quality of life, to be shared with authorities and scientific community
    Clinical Trial Phase III Study Allergen Immunotherapy HAL Allergy House Dust Mite Allergy
    Logo of HAL Allergy B.V.
Accesswire
  • Published on 10/24/2026 at 00:25, 1 day 23 hours ago

    Caldwell Announces Sale of IQTalent

  • Published on 10/24/2026 at 00:04, 1 day 23 hours ago

    Sparta Capital Ltd. Provides Corporate Update on Reinstatement Review, Financial Statement Corrections and Governance Matters

  • Published on 10/23/2026 at 23:30, 1 day 23 hours ago

    Algo Grande Commissions Independent NI 43-101 Update to Capture First Year of Progress at Adelita

  • Published on 10/23/2026 at 21:55, 2 days 1 hour ago

    Apex Closes Offering and Completes NASDAQ Listing

  • Published on 10/23/2026 at 16:00, 2 days 7 hours ago

    Leggett Dynamics's Mid-Class Massage System Wins Gasgoo's Best Technical Practice Award

View all ACCESSWIRE
EQS Group
  • Published on 10/24/2026 at 23:44, 24 hours 42 minutes ago

    EQS-Adhoc: HomeToGo SE: Unauthorized data exfiltration at subsidiary SECRA Bookings GmbH

  • Published on 10/24/2026 at 14:15, 1 day 9 hours ago

    Winners of the 2026 INPD Awards Announced, C-Beauty Takes Home Multiple Prestigious Honors

  • Published on 10/24/2026 at 06:30, 1 day 16 hours ago

    AI and EV Boom Draws $690 Million in Advanced Materials Investment Plans to Thailand

  • Published on 10/23/2026 at 18:55, 2 days 4 hours ago

    Qatar's Years of Culture Initiative Announces Partner Countries Through 2030

  • Published on 10/23/2026 at 18:00, 2 days 5 hours ago

    BIOSYNEX SA: CHEMBIO DIAGNOSTIC SYSTEMS AWARDED $5.7 MILLION TO ADVANCE DPP® BIOTHREAT PANEL

View all EQS
Les Echos
  • Published on 10/23/2026 at 20:33, 2 days 2 hours ago

    Disclosure of transactions in own shares from October 19 to October 23, 2026

  • Published on 10/23/2026 at 17:45, 2 days 5 hours ago

    Imerys-10-2026-information-share-capital-and-voting-rights-as-of-30-September-2026

  • Published on 10/23/2026 at 07:00, 2 days 16 hours ago

    Safran reports third quarter 2026 revenue

  • Published on 10/22/2026 at 18:00, 3 days 5 hours ago

    THERMADOR GROUPE : Completion of the share buy-back programme launched in August

  • Published on 10/22/2026 at 18:00, 3 days 5 hours ago

    bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy